Wonderlight is also said to be suitable for use in cosmetics designed for the Japanese market where lightening products are classified as quasi-drugs.
Wonderlight’s ability to inhibit the UV induced secretion of melanocyte stimulator GM-CSF was demonstrated in vitro and two clinical trials conducted on Asian volunteers with pigment disorders including lentigines, ephelides, melasma and post inflammatory hyperpigmentation further confirmed its melanogenesis reducing activity.
